CCL11 and breast cancer: Wang et al. demonstrated that the serum CCL11 level and the proportion of immunosuppressive T regulatory significantly increased in patients with breast cancer compared with healthy individuals and blockade of CCL11 in tumor bearing mice decreases immunosuppressive Tregs [36].